1. Ando R, Hirooka K, Saito M, Kase S, Noda K, Ishida S. Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Jpn J Ophthalmol. 2023; 67: 50-58
2. Arita T, Namba K, Iwata D, Suzuki K, Ogino Y, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of tubulointerstitial nephritis and uveitis syndrome accompanied by subclinical choroiditis. BMC Ophthalmol. 2023; 23:424
3. Endo H, Kase S, Takahashi M, Ito Y, Sonoda S, Sakoguchi T, Sakamoto T, Katsuta S, Ishida S, Kase M. Changes in choriocapillaris structure occurring in idiopathic macular hole before and after vitrectomy. Graefes Arch Clin Exp Ophthalmol. 2023; 261: 1901-1912.
4. Igarashi T, Kase S, Suimon Y, Takakuwa E, Ishida S. A case of conjunctival cyst with apocrine hidrocystoma-like features: a clinicopathological study. Int J Ophthalmol. 2023; 16: 465-467
5. Ishida S, Chen SJ, Murata T, Ogura Y, Ruamviboonsuk P, Sakamoto T, Fujita T, Kawano M, Ohsawa S, Abreu F, Haskova Z, Ives J, Silverman D, Yoon YH; YOSEMITE and RHINE Investigators. Efficacy, Durability, and Safety of Faricimab in Patients From Asian Countries With Diabetic Macular Edema: 1-Year Subgroup Analysis of the Phase III YOSEMITE and RHINE Trials. Asia Pac J Ophthalmol. 2023; 12: 451-459
6. Kikuchi K, Tagawa Y, Murata M, Ishida S. Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats. Invest Ophthalmol Vis Sci. 2023; 64: 27
7. Kiuchi Y, Inoue T, Shoji N, Nakamura M, Tanito M, Glaucoma Guideline Preparation Committee, Japan Glaucoma Society (・・・・・, Chin S, ・・・・・, Shinmei Y, ・・・・・) . The Japan Glaucoma Society guidelines for glaucoma 5th edition. Jpn J Ophthalmol. 2023; 67: 189-254
8. Matsumoto K, Kase S, Namba K, Iwata D, Matsuno Y, Ishida S. A case of intraocular metastasis of lung cancer diagnosed using cell block preparation of vitreous humor. Cancer Diagn Progn. 2023; 3: 130-134
9. Mitamura M, Endo H, Kase S, Dong Z, Takahashi M, Katsuta S, Kase M, Ishida S. Peripapillary circulatory dysfunction precedes structural loss in treatment-naive diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2023; 261: 85-95
10. Mitamura M, Kase S, Hirooka K, Endo H, Ito Y, Ishida S. Choroidal circulatory and vascular morphological changes in acute macular neuroretinopathy after infection with severe acute respiratory syndrome coronavirus 2: a case report with literature review. In V 2023; 37: 2869-2876
11. Mitamura M, Kase S, Hirooka K, Ishida S. A case of choroidal melanocytosis observed by multimodal imaging with laser speckle flowgraphy. BMC Ophthalmol. 2023; 23: 180
12. Mitamura M, Kase S, Hirooka K, Ishida S. Alterations of choroidal circulation and choroidal thickness before and after chemoradiotherapy in a case of metastatic choroidal tumor. BMC Ophthalmol. 2023; 23: 270
13. Mitamura M, Kase S, Yamashita Y, Hirooka K, Ishida S. Alterations in choroidal circulatory dynamics and choroidal thickness before and after treatment in posterior scleritis. BMC Ophthalmol. 2023; 23: 382
14. Mitamura M, Noda K, Kase S, Hirooka K, Ishida S. Retinal hypoperfusion detected by wide-field optical coherence tomographic angiography in a case of retinal racemose hemangioma. Retin Cases Brief Rep. 2023; 17: 723-727
15. Ogino Y, Namba K, Iwata D, Suzuki K, Mizuuchi K, Hiraoka M, Kitaichi N, Ishida S. A case of APMPPE-like panuveitis presenting with extensive outer retinal layer impairment following COVID-19 vaccination. BMC Ophthalmol. 2023; 23: 233
16. Shinagawa M, Namba K, Mizuuchi K, Iwata D, Hase K, Suzuki K, Hirooka K, Kitaichi N, Hiraoka M, Ishida S. The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt–Koyanagi–Harada Disease. Ocul Immunol Inflamm. 2023; 31: 501-505
17. Sugita S, Usui Y, Watanabe H, Panto L, Iida M, Suginoshita K, Koyanagi KO, Nishida A, Kurimoto Y, Takahashi M, Shindo T, Nishioka H, Takano M, Kezuka T, Goto H, Kitaichi N. Adenovirus-associated uveitis with necrotizing retinitis. Ophthalmology. 2023; 130: 443-445
18. Suzuki K, Iwata D, Namba K, Hase K, Hiraoka M, Murata M, Kitaichi N, Foxton R, Ishida S. Involvement of Angiopoietin 2 and vascular endothelial growth factor in uveitis. PLoS One. 2023; 18: e0294745
19. Suzuki K, Shinmei Y, Hirooka K, Kanaya R, Shinkai A, Kijima R, Chin S, Ito Y M, Ishida S. Reduction of intraocular pressure and aqueous outflow resistance after modified 360-degree suture trabeculotomy. J Glaucoma. 2023; 32: 204-209
20. Takeuchi M, Usui Y, Namba K, Keino H, Takeuchi M, Takase H, Kamoi K, Hase K, Ito T, Nakai K, Maruyama K, Kobayashi E, Mashimo H, Sato T, Ohguro N, Hori J, Okada AA, Sonoda KH, Mizuki N, Goto H. Ten-year follow-up of infliximab treatment for uveitis in Behcet disease patients: A multicenter retrospective study. Front Med. 2023; 10: 1095423
21. Yamamoto T, Kase S, Shinkai A, Murata M, Kikuchi K, Wu D, Kageyama Y, Shinohara M, Sasase T, Ishida S. Phosphorylation of αB-crystallin involves interleukin-1β-mediated intracellular retention in retinal Müller cells. Invest Ophthalmol Vis Sci. 2023; 64: 20.